Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's
We haven't written up this one. Economic Times Tech has the full story — the link below goes straight to it.